CANB — Can B Share Price
Last trade - 00:00- $4.57m
- $21.33m
- $2.16m
- 43
- 20
- 83
- 47
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 18.53 | ||
| Price to Sales | 4.42 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -1035.9% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 2.31 | 1.71 | 4.6 | 6.69 | 2.16 | n/a | n/a | 26.38% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Can B Corp. is a health and wellness company. The Company is engaged in developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. Its products include oils, creams, moisturizers, isolates, gel caps, spa products, and concentrates and lifestyle products. It develops its own line of proprietary products, as well as seeks synergistic value through acquisitions in the hemp industry. Its Duramed Division provides a sam Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients' needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient, who signs a rental form, for a 35-day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. The Company is also focuses on protecting and commercializing the cannabis patents covering liquid formulations of cannabis.
Directors
- Marco Alfonsi CHM (55)
- Stanley Teeple CFO (69)
- Philip Scala COO
- Romuald Stone CTO (39)
- S. Neil Ford DRC
- Frederick Boyer IND
- James Murphy IND
- Senator Ronald Silver IND
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- October 11th, 2005
- Public Since
- March 11th, 2011
- No. of Shareholders
- 250
- No. of Employees
- 12
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 75,841,988
- Address
- 960 South Broadway, Suite 120, HICKSVILLE, 11801
- Web
- https://www.canbcorp.com/
- Phone
- +1 5162054751
- Auditors
- B F Borgers CPA PC
Latest News for CANB
Upcoming Events for CANB
Q4 2024 Can B Corp Earnings Release
Q1 2025 Can B Corp Earnings Release
Q2 2025 Can B Corp Earnings Release
Similar to CANB
American Green
Pink Sheets on Nasdaq
Bit Brother
Pink Sheets on Nasdaq
Blue Gem Enterprise
Pink Sheets on Nasdaq
Blum Holdings
Pink Sheets on Nasdaq
Cbd of Denver
Pink Sheets on Nasdaq
FAQ
As of Today at 19:45 UTC, shares in Can B are trading at $0.06. This share price information is delayed by 15 minutes.
Shares in Can B last closed at $0.06 and the price had moved by +72% over the past 365 days. In terms of relative price strength the Can B share price has outperformed the S&P500 Index by +60.69% over the past year.
The overall consensus recommendation for Can B is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCan B does not currently pay a dividend.
Can B does not currently pay a dividend.
Can B does not currently pay a dividend.
To buy shares in Can B you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.06, shares in Can B had a market capitalisation of $4.57m.
Here are the trading details for Can B:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CANB
Based on an overall assessment of its quality, value and momentum Can B is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Can B is $10.00. That is 16511.3% above the last closing price of $0.06.
Analysts covering Can B currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Can B. Over the past six months, its share price has outperformed the S&P500 Index by +81.94%.
As of the last closing price of $0.06, shares in Can B were trading +69.35% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Can B PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Can B's management team is headed by:
- Marco Alfonsi - CHM
- Stanley Teeple - CFO
- Philip Scala - COO
- Romuald Stone - CTO
- S. Neil Ford - DRC
- Frederick Boyer - IND
- James Murphy - IND
- Senator Ronald Silver - IND